LongevityNext

Intervention

UBX0101

Source-reviewedGoverned LongevityNext intelligence profile
Evidence reviewed through2026-08-07

Executive intelligence snapshot

Current reviewed view

The Phase 2 pain endpoint was negative, and the sponsor separately decided not to progress UBX0101 into pivotal studies.

This profile includes 2 reviewed relationship(s) and 7 reviewed source(s).

This view is bounded by reviewed evidence and does not provide a recommendation or a claim beyond the stated review date.

Evidence state

Source-reviewed

Evidence reviewed through2026-08-07

Evidence state

What the evidence supports

The Phase 2 pain endpoint was negative, and the sponsor separately decided not to progress UBX0101 into pivotal studies.

Evidence boundary

Key limitations

  • The study did not establish that cellular senescence is irrelevant to osteoarthritis or that every senolytic strategy lacks activity.

    Does not establish efficacy, mechanism falsification, approval, utility, rejuvenation, or investment attractiveness.

Not established

Key unknowns

  • Dose, route, population, and outcomes not recorded in this reviewed profile remain unknown.

    The reviewed evidence does not resolve this dimension beyond the recorded boundary.

Next evidence milestone

What would change this view?

No specific evidence milestone is recorded yet.

Evidence reviewed through 2026-08-07.

Intelligence connections

Reviewed source layer

Evidence & sources

These cards show only metadata present in the reviewed source registry.

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

Technical provenance
Object key
intervention:LNPG-ENT-ef775c3f-ec9c-40e0-b5ba-14ffab8da28e
Source release
LNPG-REL-20260807-027
Mapping version
0.2.0
Presentation release
LNPG-REL-20260808-037
Projection hash
2514946e4bdc9ea6d447ac8c9135ba1cc2cce34b9d613ae9ff7bf7a4605aeb0f

Source identifiers

  • LNPG-SRC-267009f7-a006-4adc-a8b6-18fbb89b2574
  • LNPG-SRC-5a15692d-c9aa-4d2d-a349-14831bd61076
  • LNPG-SRC-74e4d09b-6c46-4399-85df-b00de793e40a
  • LNPG-SRC-c601f69e-d6a0-4336-a95c-f06a366375f4
  • LNPG-SRC-c6cddcf0-4b0d-4d37-9b4c-9665f7e9f4c0
  • LNPG-SRC-cffb8337-dc19-456d-b67e-5ab9ac505b8b
  • LNPG-SRC-d9a27303-442b-423c-b752-95cf87597c15

Directed relationship identities

  • edge:00214 — intervention_exactly_links_company
  • edge:00221 — intervention_tested_in_trial

Scores are not displayed because no score methodology is qualified for this profile.

Presentation contract

Snapshot mode
DIRECT_GOVERNED_SUMMARY
Opens in a new tab